Compare CBSH & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBSH | BIO |
|---|---|---|
| Founded | 1865 | 1952 |
| Country | United States | United States |
| Employees | N/A | 7450 |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 7.1B |
| IPO Year | 2008 | N/A |
| Metric | CBSH | BIO |
|---|---|---|
| Price | $50.52 | $277.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 4 |
| Target Price | $59.22 | ★ $339.75 |
| AVG Volume (30 Days) | ★ 985.1K | 282.4K |
| Earning Date | 04-21-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.05% | N/A |
| EPS Growth | ★ 4.39 | N/A |
| EPS | ★ 4.04 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $17.20 | $2.59 |
| Revenue Next Year | $3.44 | $3.21 |
| P/E Ratio | $12.66 | ★ $9.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $46.99 | $211.43 |
| 52 Week High | $66.31 | $343.12 |
| Indicator | CBSH | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 55.48 | 52.60 |
| Support Level | $46.99 | $256.85 |
| Resistance Level | $54.52 | $289.61 |
| Average True Range (ATR) | 0.90 | 7.87 |
| MACD | 0.44 | 1.42 |
| Stochastic Oscillator | 75.59 | 61.26 |
Commerce Bancshares Inc operates as the bank holding company for Commerce Bank. The bank is engaged in the general banking business, providing a broad range of retail, mortgage banking, corporate, investment, trust, and asset management products and services to individuals, businesses, and municipalities. It operates through three segments: Consumer, Commercial, and Wealth. The Commercial segment provides corporate lending, payment solutions, leasing, international services, and business banking. The Consumer segment covers retail banking, mortgages, installment lending, and card services. The Wealth segment offers trust and estate planning, brokerage, and investment management services.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.